Could the controversial COVID drug hydroxychloroquine be repurposed as a promising medication for cancer? Researchers believe ...

Provenge (sipuleucel-T) is created by exposing the immune cells of someone with prostate cancer to a protein that “teaches” ...

According to a Boston University study head and neck cancer (HNC) trials have been less diverse between 2000 and 2023.

The phase 2 INVINCIBLE-4 clinical trial is currently underway in patients with localized triple-negative breast cancer.

In Louisiana and across the country, pancreatic cancer continues to be one of the most aggressive and deadly forms of the ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the ...

Boston is a city recognized worldwide for its cutting-edge advancements in science and medicine, especially in the field of ...

A powerful, three-drug therapy for aggressive advanced breast cancer doubles the length of time before the cancer progresses, ...

A new clinical trial highlights that spotting a genetic subtype of these ATC tumors can be key to designing treatment that ...

The University of Birmingham’s Cancer Research UK Clinical Trials Unit is leading a new trial to improve outcomes for ...

A three-drug therapy targeting breast cancer could double the amount of time patients live without the disease progressing, a trial has found. Researchers praised the “huge breakthrough” as ...

NCH has forged an affiliation with Northwestern Medicine to improve cancer care and provide access to clinical trials.